Fintel reports that on November 11, 2025, Baird maintained coverage of Global Medical REIT (NYSE:GMRE) with a Neutral recommendation.
Fintel reports that on November 11, 2025, Baird maintained coverage of Global Medical REIT (NYSE:GMRE) with a Neutral recommendation.